Evidence map›Paper›PMID 37324463›Full record

ArticleFrontiers in pharmacology2023

Prophylactic rivaroxaban in the early post-discharge period reduces the rates of hospitalization for atrial fibrillation and incidence of sudden cardiac death during long-term follow-up in hospitalized COVID-19 survivors.

Lukas Fiedler, Lukas J Motloch, Anna-Maria Dieplinger, Peter Jirak, Paruir Davtyan, Diana Gareeva, Elena Badykova, Marat Badykov, Irina Lakman, Aleksandr Agapitov and 10 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 5 institutions in 4 countries.

Lukas FiedlerUniversity Department of Internal Medicine II, Cardiology and Internal Intensive Care Medicine, Paracelsus Medical University, Salzburg, Austria.
Lukas J MotlochUniversity Department of Internal Medicine II, Cardiology and Internal Intensive Care Medicine, Paracelsus Medical University, Salzburg, Austria.
Anna-Maria DieplingerNursing Science Program, Institute for Nursing Science and Practice, Paracelsus Medical University, Salzburg, Austria.
Peter JirakUniversity Department of Internal Medicine II, Cardiology and Internal Intensive Care Medicine, Paracelsus Medical University, Salzburg, Austria.
Paruir DavtyanDepartment of Internal Diseases, Bashkir State Medical University, Ufa, Russia.
Diana GareevaDepartment of Internal Diseases, Bashkir State Medical University, Ufa, Russia.
Elena BadykovaDepartment of Internal Diseases, Bashkir State Medical University, Ufa, Russia.
Marat BadykovDepartment of Internal Diseases, Bashkir State Medical University, Ufa, Russia.
Irina LakmanDepartment of Internal Diseases, Bashkir State Medical University, Ufa, Russia.
Aleksandr AgapitovScientific Laboratory for the Socio-Economic Region Problems Investigation, Ufa University of Science and Technology, Ufa, Russia.
Liana SadikovaScientific Laboratory for the Socio-Economic Region Problems Investigation, Ufa University of Science and Technology, Ufa, Russia.
Valentin PavlovDepartment of Urology, Bashkir State Medical University, Ufa, Russia.
Fabian FöttingerUniversity Department of Internal Medicine II, Cardiology and Internal Intensive Care Medicine, Paracelsus Medical University, Salzburg, Austria.
Moritz MirnaUniversity Department of Internal Medicine II, Cardiology and Internal Intensive Care Medicine, Paracelsus Medical University, Salzburg, Austria.
Kristen KoppUniversity Department of Internal Medicine II, Cardiology and Internal Intensive Care Medicine, Paracelsus Medical University, Salzburg, Austria.
Uta C HoppeUniversity Department of Internal Medicine II, Cardiology and Internal Intensive Care Medicine, Paracelsus Medical University, Salzburg, Austria.
Rudin PistulliDepartment of Cardiology I, Coronary and Peripheral Vascular Disease, Heart Failure, University Hospital Muenster, Muenster, Germany.
Benzhi CaiDepartment of Pharmacology (The Key Laboratory of Cardiovascular Medicine Research, Ministry of Education), College of Pharmacy, Harbin Medical University, Harbin, China.
Baofeng YangDepartment of Pharmacology (The Key Laboratory of Cardiovascular Medicine Research, Ministry of Education), College of Pharmacy, Harbin Medical University, Harbin, China.
Naufal ZagidullinDepartment of Internal Diseases, Bashkir State Medical University, Ufa, Russia.
Bashkir State Medical University · RUParacelsus Medical University · ATHarbin Medical University · CNFachhochschule Wiener Neustadt · ATUniversity Hospital Münster · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

atrial fibrillationCOVID-19long COVID-19NOACpost-acute COVID-19 sequelaerivaroxabanSCD

Identifiers

PMID37324463
PMCPMC10266094
OpenAlexW4378902087

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.